COVID-19 vaccine: DCGI grants approval to Covishield, Covaxin; Modi terms it 'decisive turning point'

The DCGI's approval was given on the basis of recommendations submitted by a COVID-19 subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO)

FP Staff January 03, 2021 12:20:15 IST
COVID-19 vaccine: DCGI grants approval to Covishield, Covaxin; Modi terms it 'decisive turning point'

The DCGI chief addressing the media on Sunday. ANI

India's drugs regulator on Sunday approved Oxford's COVID-19 vaccine Covishield, manufactured by the Serum Institute of India, and the indigenously-developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.

The approval by the Drugs Controller General of India (DCGI) was given on the basis of recommendations submitted by a COVID-19 subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).

“After adequate examination, CDSCO has decided to accept the recommendations of the Expert Committee and accordingly, vaccines of M/s Serum and M/s Bharat Biotech are being approved for restricted use in emergency situation," DCGI Dr V G Somani told a press conference.

This paves the way for the roll out of at least two vaccines in India in the coming days.

COVID19 vaccine DCGI grants approval to Covishield Covaxin Modi terms it decisive turning point

FOLLOW LIVE UPDATES ON coronavirus VACCINE HERE

Prime Minister Narendra Modi termed the approvals as a 'decisive turning point' in the fight against the novel coronavirus and said, "It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, at the root of which is care and compassion."

Serum Institute of India’s CEO Adar Poonawalla tweeted —

Dr Poonam Khetrapal Singh, Regional Director WHO South-East Asia Region, said, "WHO welcomes the first emergency use authorization given to COVID-19 vaccine in the WHO South-East Asia Region. This decision taken today by India will help intensify and strengthen the fight against COVID-19 pandemic in the Region. The use of vaccine in prioritized populations, along with continued implementation of other public health measures and community participation will be important in reducing the impact of COVID-19 ."

The Serum Institute of India, the world's largest vaccine manufacturer, has tied up with AstraZeneca to manufacture Covishield.

Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

Also, the authority granted Cadila Healthcare the permission to conduct the Phase III clinical trial of its vaccine candidate in India, Somani said.

With inputs from PTI

Updated Date:

also read

Coronavirus News Updates: Delhi's tally of patients with new COVID-19 strain rises to 9; no UK variant in Mizoram, says health minister
Health

Coronavirus News Updates: Delhi's tally of patients with new COVID-19 strain rises to 9; no UK variant in Mizoram, says health minister

Coronavirus News Updates: Mizoram health minister Dr R Lalthangliana said seven state residents have so far returned from the United Kingdom and all of them tested negative for the mutant coronavirus as well as COVID-19

No foreign dignitary at R-Day parade due to COVID-19 crisis; new cases under 20,000 for 7th day
India

No foreign dignitary at R-Day parade due to COVID-19 crisis; new cases under 20,000 for 7th day

In view of the global COVID-19 situation, the Centre has decided not to have a foreign dignitary present at the Republic Day celebrations this year. It will be for the first time in over five decades that there will be no chief guest at the Republic Day parade

Flights ferry COVID-19 vaccine to 13 cities ahead of roll out on 16 Jan; preparations on track, says health ministry
India

Flights ferry COVID-19 vaccine to 13 cities ahead of roll out on 16 Jan; preparations on track, says health ministry

India on Tuesday recorded 12,584 new cases of coronavirus, the lowest in around seven months, taking the country's COVID-19 caseload to1,04,79,179, as per the Union health ministry's morning update